Keywords: brazil, oks, ranbaxy, generic, lamivudine, regulatory, authority
Brazil OKs Ranbaxy's generic lamivudine
Article | 23 July 2001
Brazil's regulatory authority, the ANVS, has approved Ranbaxy S PMedicamentos' generic version of GlaxoSmithKline's Epivir (lamivudine). The firm, a joint ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- US Supreme Court says patent settlement can "sometimes" be illegal
- Negative US patent ruling for Novo Nordisk on Prandin
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
